Gilenya in Amyotrophic Lateral Sclerosis (ALS)

NCT01786174 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Gilenya
OTHER: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]